"Vaccine manufacturers are making next generation vaccines to try and stay one step ahead, but it is unpredictable. So you need other interventions to address the potential evolution of the virus," Hazuda said.
"More than a year into the pandemic only one antiviral treatment — remdesivir — is currently recommended for use in the U.S., and experts say it is not nearly effective enough."
Scientists are hopeful that new drugs designed to stop the virus' deadly reproduction could reduce hospitalizations and deaths from COVID-19.
Their drug,
molnupiravir, is one of two powerful medicines to treat COVID-19 that are nearing the end of clinical testing."
Ivermectin is the original Merk Molnupiravir, kinda cheap generic version Merk can't make $$$ off, Molnupiravir they can have a patent.
If they are vastly different please prove me wrong, I'd rather be right than wrong.
"Merck Tests Molnupiravir, an Investigational Product, at the Lung Center of the Philippines While Large Ivermectin Trial Runs in Parallel
https://www.google.com/url?sa=t&sou...Vaw03hVnVcuxgnFfW0S1QOdKI&cshid=1629597479108
The United States is devoting $3.2 billion to speed development of antiviral pills to treat COVID-19 and other dangerous viruses that could turn into pandemics.
the U.S. said it would purchase 1.7 million doses of an experimental antiviral pill from Merck and Ridgeback Biotherapeutics, if it is shown to be safe and effective,
Molnupiravir.
https://www.google.com/url?sa=t&sou...UQFnoECAQQAQ&usg=AOvVaw3aUM39iHUaBRASBbGp8jQI